Q3 preview: Seat decline to continue, margin to recover

Q3 preview (19 Nov): sales seen -3.4% yoy to €21.1m, adj. EBITDA €2.5m (11.8% margin). FY guidance well in reach, lower ends likely. AI progress key metric to track. BUY, unchanged PT €5.00.